BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30842151)

  • 21. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
    Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
    Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inducing pluripotency in somatic cells from the snow leopard (Panthera uncia), an endangered felid.
    Verma R; Holland MK; Temple-Smith P; Verma PJ
    Theriogenology; 2012 Jan; 77(1):220-8, 228.e1-2. PubMed ID: 22079579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gata4 blocks somatic cell reprogramming by directly repressing Nanog.
    Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R
    Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is iPS cell the panacea?
    Ou L; Wang X; Zou F
    IUBMB Life; 2010 Mar; 62(3):170-5. PubMed ID: 20146301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
    Heffernan C; Sumer H; Verma PJ
    J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
    Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
    Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Midkine and NANOG Have Similar Immunohistochemical Expression Patterns and Contribute Equally to an Adverse Prognosis of Oral Squamous Cell Carcinoma.
    Kim HM; Kang YH; Byun JH; Jang SJ; Rho GJ; Lee JS; Park BW
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29113102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
    Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
    Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
    Cheng D; Lei L; Lu Z; Li Z; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Putative cancer stem cells are present in surgical margins of oral squamous cell carcinoma.
    Lazarevic M; Milosevic M; Trisic D; Toljic B; Simonovic J; Nikolic N; Mikovic N; Jelovac D; Petrovic M; Vukadinovic M; Milasin J
    J BUON; 2018; 23(6):1686-1692. PubMed ID: 30610795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
    Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
    Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma.
    Park E; Park SY; Sun PL; Jin Y; Kim JE; Jheon S; Kim K; Lee CT; Kim H; Chung JH
    Oncotarget; 2016 Jul; 7(27):42502-42512. PubMed ID: 27285762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
    Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
    Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mediators of induced pluripotency and their role in cancer cells - current scientific knowledge and future perspectives.
    Bernhardt M; Galach M; Novak D; Utikal J
    Biotechnol J; 2012 Jun; 7(6):810-21. PubMed ID: 22589234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KLF4 and NANOG are prognostic biomarkers for triple-negative breast cancer.
    Nagata T; Shimada Y; Sekine S; Moriyama M; Hashimoto I; Matsui K; Okumura T; Hori T; Imura J; Tsukada K
    Breast Cancer; 2017 Mar; 24(2):326-335. PubMed ID: 27300169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
    Lee S; Wottrich S; Bonavida B
    Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
    Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
    Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 40. Positive expression of NANOG, mutant p53, and CD44 is directly associated with clinicopathological features and poor prognosis of oral squamous cell carcinoma.
    Lee HJ; Kang YH; Lee JS; Byun JH; Kim UK; Jang SJ; Rho GJ; Park BW
    BMC Oral Health; 2015 Dec; 15(1):153. PubMed ID: 26626427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.